Top 10 Biotechnology Angel Investors in Belgium in January 2026
A list of 10 angel investors that invest in Biotechnology startups based in Belgium. We rank investors based on the number of investments they made in Biotechnology companies from Belgium. We update this investor list every month.Top 10 Biotechnology Angel Investors in Belgium in January 2026
| Investor | Biotechnology Belgium investments |
|---|---|
| Pierre Drion | 3 |
| Annie Vereecken | 3 |
| Luc Vauterin | 2 |
| Herman Verrelst | 1 |
| Evren Ucok | 1 |
| Jean Dessain | 1 |
| Yves Beudin | 1 |
| Virginie Saverys | 1 |
| Patrick Keereman | 1 |
| Kenneth Buckfire | 1 |
Pierre Drion - CEO @ Petercam
Show more
Investment focus
- Biotechnology, Health Care, Life Science
- Series A, Series B, Funding Round
- Belgium
Portfolio highlights
- A-Mansia Biotech — A-Mansia Biotech is a developer of products based on the properties of the Akkermansia muciniphila (A. muciniphila) bacterium. The company's nutritional supplement based on a gut bacterium called Akkermansia, the population of microorganisms housed in the gastrointestinal tract. A. muciniphila is located in the mucus layer covering theintestinal epithelium, which allows the bacterium to establish a close cross-talk with the host.
- Novadip Biosciences — Novadip Biosciences, an advanced biopharmaceutical company focused on new generation of therapies from adipose stem cells adapted to hard and soft tissues reconstruction.
- Santero Therapeutics — This is the homepage of the website
Annie Vereecken
Show more
Investment focus
- Biotechnology, Medical, Hospital
- Seed, Series A, Funding Round
- Belgium
Portfolio highlights
- Ziphius — Ziphius Vaccines is a biopharmaceutical company dedicated to developing next-generation vaccines for the prevention of infectious diseases.
- Sensolus — Sensolus provides care-free tracking of your valuable non-powered assets directly from the cloud.Sensolus offers turnkey solutions for wireless, low-power context-aware sensing. Sensolus developed a personal product line of low-power tracker systems called STICKNTRACK.Sensolus is built upon many years of expertise in low-power networks,wireless sensor design, cloud-based sensor management, analytics, and applications.
- Allegro Biotech — Allegro has developed the world’s-first custom-tailored, durable, biocompatible, anisotropic, regenerative meniscus cartilage, providing immediate support while also leverage the body’s own healing potential to regenerate human cartilage (proliferation and differentiation of fibrochondrocyte cells).
Luc Vauterin - Board Member @ ONTOFORCE
Show more
Investment focus
- Life Science, Data Integration, Data Visualization
- Seed, Series A
- Belgium
Portfolio highlights
- ONTOFORCE — ONTOFORCE creates and implements pioneering semantic search technology for information management. Our user-friendly data search platform DISQOVER builds uniquely intelligent links between heterogeneous data sources, allowing everybody to become a data scientist.
Herman Verrelst
Show more
Investment focus
- Medical, Hospital, Biotechnology
- Series A
- Belgium
Portfolio highlights
- UgenTec — FastFinder is intelligent software that automates sample workflow, ensures your assays are analyzed consistently and cuts data analysis time in half.
Evren Ucok is a co-founder and investor at Peak Games, an interactive social game development platform.
He is also a partner at Earlybird Venture Capital, an investment fund-based in Europe that focuses on emerging companies; Trendyol.com, a fashion e-commerce site; and Oliver Wyman.
Show more
Investment focus
- Medical, Health Care, Life Science
- Series A
- Turkey, Belgium
Portfolio highlights
- idemama — Idemama is an online platform that provides its users with web and graphic design services. It is based in Istanbul, Turkey.
- Amyl Therapeutics — Amyl Therapeutics is a preclinical stage biotechnology company. Amyl Therapeutics uses a novel mechanism to bind to the amyloid fold of toxic protein aggregates of various types, including antibody light chain (AL) or transthyretin (TTR) aggregates, which accumulate in peripheral organs to cause systemic amyloidosis diseases, but also amyloid-β(Aβ), Tau, and α-synuclein aggregates, which accumulate in the brain to cause Alzheimer's and Parkinson's diseases.
Jean Dessain - Non Executive Director @ OneLIFE
Show more
Investment focus
- Medical, Health Care, Biotechnology
- Angel
- Belgium
Portfolio highlights
- OneLIFE — Enzymatic cleaning solutions against soiling and biofilms for medical devices and the hospital environment. Safe for staff, patients and visitors.
Yves Beudin
Show more
Investment focus
- Medical, Health Care, Biotechnology
- Angel
- Belgium
Portfolio highlights
- OneLIFE — Enzymatic cleaning solutions against soiling and biofilms for medical devices and the hospital environment. Safe for staff, patients and visitors.
Virginie Saverys is a entrepreneur.
Show more
Investment focus
- Medical, Life Science, Biotechnology
- Seed
- Belgium
Portfolio highlights
- 4Tissue — Shaping the Future of Regenerative Medicine
Patrick Keereman
Show more
Investment focus
- Medical, Hardware, Software
- Seed
- Belgium
Portfolio highlights
- MOLECUBES — MOLECUBES is a Ghent University spin-off started with the support of iMinds. Springing from the MEDISIP research group and the preclinical INFINITY lab, a team of young hardware and software engineers with hands-on experience grouped together to make a difference in their and your daily imaging practice.We build preclinical imaging cubesallowing you to combine SPECT, PET and CT imaging in almost any lab space. Modular systems leave full flexibility at your side while ensuring full mice and full rat imaging. Intuitive wireless acquisition and reconstruction software allow the systems to be used almost anywhere by anyone. Being built by end-users we also understand the importance of good servicing.
Kenneth Buckfire is the Chief Executive Officer at Miller Buckfire.
Show more
Investment focus
- Medical, Health Care, Life Science
- Series A
- Belgium
Portfolio highlights
- Amyl Therapeutics — Amyl Therapeutics is a preclinical stage biotechnology company. Amyl Therapeutics uses a novel mechanism to bind to the amyloid fold of toxic protein aggregates of various types, including antibody light chain (AL) or transthyretin (TTR) aggregates, which accumulate in peripheral organs to cause systemic amyloidosis diseases, but also amyloid-β(Aβ), Tau, and α-synuclein aggregates, which accumulate in the brain to cause Alzheimer's and Parkinson's diseases.
Investors by industry
Community
Artificial intelligence
Hardware
Marketplace
Consumer
FinTech
Energy
Gaming
Impact
Climate
Proptech
Google
Biotech
Health Care
EdTech
Sustainability
Venture Capital
Clean Energy
Web3
Art
Wellness
Organic Food
Android
Big Data
Digital Media
Manufacturing
Video Games
Publishing
Construction
Sports
B2B
Franchise
Food and Beverage
eSports
Payments
Mobile
Real Estate
Enterprise Software
Music
Finance
Email
Education
Social Media
Social Network
Financial Services
Medical
Legal
Retail
Local
Internet
Infrastructure
Biotechnology
Travel
Fitness
Recruiting
Hospitality
Beauty
Mobile Advertising
Platforms
Cannabis
Photography
Automotive
Social
Wine And Spirits
Medical Device
CleanTech
Crowdfunding
Mobile Apps
InsurTech
Transportation
Enterprise
LGBT
Film
Oil and Gas
Fashion
Life Science
Theatre
Non Profit
SaaS
Renewable Energy
Sporting Goods
Restaurants
Software
Celebrity
Social Impact
Cryptocurrency
Facebook
Machine Learning
Agriculture (agtech)
Media (entertainment)
Blockchain
Investors by country
New Zealand
Ireland
Canada
United States
India
Germany
United Kingdom
South Korea
Australia
Middle East
Indonesia
South Africa
Sri Lanka
Vietnam
Ghana
Europe
Egypt
Belarus
Hungary
Qatar
Japan
Finland
Singapore
France
Croatia
Spain
Gibraltar
Barbados
Georgia
China
Greece
Armenia
Czech Republic
Faroe Islands
Costa Rica
Hong Kong
Saudi Arabia
Bahrain
Belgium
Oceania
Denmark
Bermuda
Africa
Estonia
Algeria
Ecuador
LATAM
Bulgaria
Belize
Chile
Asia
Ethiopia
Liechtenstein
Panama
Myanmar
Lithuania
Malaysia
Peru
Brazil
Liberia
Jersey
Lebanon
Norway
Togo
Mexico
Italy
Mali
Philippines
Rwanda
Israel
Kuwait
Mauritius
Malta
Morocco
Slovenia
Nicaragua
Dominican Republic
Poland
Bahamas
Iraq
Iceland
Uganda
Azerbaijan
Nigeria
San Marino
Sweden
Namibia
United Arab Emirates
Serbia
Jamaica
Honduras
Sierra Leone
Isle of Man
Thailand
Bolivia
Luxembourg
Pakistan
Tanzania
Albania
Uzbekistan
Zambia
Turkey
Romania
Uruguay
Jordan
Grenada
Argentina
Tajikistan
Bangladesh
Russian Federation
Portugal
El Salvador
Puerto Rico
Senegal
Zimbabwe
Tunisia
Venezuela
Ukraine
Taiwan
Kenya
Kazakhstan
Cayman Islands
Cambodia
Colombia
Cyprus
Oman
Latvia
Cameroon
Austria
Switzerland
Guatemala
Seychelles
Marshall Islands
Angel Investors in Belgium by industry
Biotechnology
Marketplace
Food and Beverage
Financial Services
Big Data
Finance
Life Science
Medical
Medical Device
Internet
Social Media
Manufacturing
Software
Sports
Enterprise Software
Mobile Advertising
Automotive
Hospitality
Enterprise
FinTech
Health Care
Biotech
SaaS
Climate
Community
Real Estate
Gaming
Transportation
Publishing
Retail
Legal
Proptech
Platforms
Payments
Artificial intelligence
Hardware
Construction
Media (entertainment)
Consumer
Machine Learning
Energy
Mobile